Phase I study of a multitargeted recombinant Ad5 PSA/MUC-1/brachyury-based immunotherapy vaccine in patients with metastatic castration-resistant prostate cancer (mCRPC).
J Immunother Cancer
; 9(3)2021 03.
Article
in En
| MEDLINE
| ID: mdl-33762322
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Kallikreins
/
Adenoviridae
/
Prostate-Specific Antigen
/
Vaccines, Combined
/
Mucin-1
/
Cancer Vaccines
/
T-Box Domain Proteins
/
Fetal Proteins
/
Prostatic Neoplasms, Castration-Resistant
Limits:
Aged
/
Aged80
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
J Immunother Cancer
Year:
2021
Document type:
Article
Affiliation country: